Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges

Published:2022-02 Issue: Volume:342 Page:345-361
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Taha Eman A.,Lee Joseph,Hotta Akitsu

Funder

Takeda Pharmaceutical Co Ltd

Japan Agency for Medical Research and Development

Japan Science and Technology Agency

National Center of Neurology and Psychiatry

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference180 articles.

1. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity;Jinek;Science,2012

2. In vivo delivery of CRISPR-Cas9 therapeutics: Progress and challenges;Behr;Acta Pharm. Sin. B,2021

3. Recent advance in CRISPR/Cas9 delivery strategies;Yip;Biomolecules,2020

4. Delivery of CRISPR/Cas9 for therapeutic genome editing;Xu;J. Gene Med.,2019

5. Minimizing off-target mutagenesis risks caused by programmable nucleases;Ishida;Int. J. Mol. Sci.,2015

Cited by 113 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review on the current status of CRISPR based clinical trials for rare diseases;International Journal of Biological Macromolecules;2024-10

2. Genome Engineering of Primary and Pluripotent Stem Cell-Derived Hepatocytes for Modeling Liver Tumor Formation;Biology;2024-09-02

3. Genetic therapies and potential therapeutic applications of CRISPR activators in the eye;Progress in Retinal and Eye Research;2024-09

4. Emerging trends in virus and virus-like particle gene therapy delivery to the brain;Molecular Therapy - Nucleic Acids;2024-09

5. Oral Microto-Nano Genome-Editing System Enabling Targeted Delivery and Conditional Activation of CRISPR-Cas9 for Gene Therapy of Inflammatory Bowel Disease;ACS Nano;2024-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3